胱抑素C在临床糖尿病肾病中的应用研究进展
被引量：1
摘要
糖尿病肾病是诱发晚期肾衰竭的高危因素,胱抑素C是评估肾小球滤过率的一种重要内源性标记物,其对糖尿病肾病的早期诊断和临床治疗起到了重要的作用。
出处
《齐齐哈尔医学院学报》
2014年第3期416-417,共2页
Journal of Qiqihar Medical University
基金
皖南医学院中青年科研基金(WK2013F31)
安徽省高校自然科学基金(KJ2013B305)
参考文献19
-
1Wild S,Roglic G,Green A,et al.Global prevalence of diabetes:Estimates for the year 2000 and projections for 2030[J] .Diabetes Care 2004,27:1047-1053.
-
2De Boer IH,Rue TC,Hall YN,et al.Temporal trends in the prevalence of diabetic kidney disease in the United States[J] .JAMA,2011,305(24):2532-2539.
-
3Kimura T,Ikeda H,Fujikawa J,et al.Usefulness of serum cystatin C in Japanese patients with type 2 diabetes mellitus and nephropathy[J] .Diabetes Res Clin Pract,2009,83:e58-e61.
-
4Sahakyan K,Lee KE,Shankar A,et al.Serum cystatin C and the incidence of type 2 diabetes mellitus[J] .Diabetologia,2011,54:1335-1340.
-
5Cockcroft DW,Gault MH.Prediction of creatinine clearance from serum creatinine[J] .Nephron,1976,16:31-41.
-
6Poggio ED,Wang X,Greene T,et al.Performance of the modification of diet in renal disease and cockcroft-gault equation in the estimation of GFR in health and in chronic kidney disease[J] .J Am Soc Nephrol,2005,16:459-466.
-
7Rule AD,Larson TS,Bergstralh EJ,et al.Using serum creatinine to estimate glomerular filtration rate:accuracy in good health and in chronic kidney disease[J] .Ann Intern Med,2004,141:929-937.
-
8Herget-Rosenthal S,Bokenkamp A,Hofmann W.How to estimate GFR-serum creatinine,serum cystatin C or equations[J] .Clin Biochem,2007,40:153-161.
-
9Schaeffner ES,Ebert N,Delanaye P,et al.Two novel equations to estimate kidney function in persons aged 70 years or older[J] .Ann Intern Med,2012,157(7):471-481.
-
10Premaratne E,MacIsaac RJ,Finch S,et al.Serial measurement of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes[J] .Diabetes Care,2008,31(5):971-973.
同被引文献12
-
1周春,卢小军,吴玉泉,费明峰.测定血清β_2微球蛋白对早期糖尿病肾病的诊断意义[J].临床军医杂志,2005,33(2):153-154. 被引量：4
-
2Genuth S,Alberti KG,Bennett P,et al.Follow-up report on the diagnosis of diabetes mellitus.The expert committee on the diagnosis and classification of diabetes mellitus[J].Diabetes Care,2003,(11):3160-3167.
-
3American Diabetes Association.Standards of(下转1265页)(上接1226页)medical care indiabetes-2011[J].Diabetes Care,2011,34(Suppl 1):11-61.
-
4Blickle JF,Doucet J,Krummel T,et al.Diabetic nephropathy in the elderly[J].Diabetes Metab,2007,33 Suppl 1:40-55.
-
5Schmaderer C,Heemann U,Moog P.Update nephrology 2013[J].MMW Fortschr Med,2013,155(9):56-59.
-
6Hirst JA,Stevens RJ,Farmer AJ.Changes in HbA,c Level over a 12-Week Follow-up in Patients with Type 2 Diabetes following a Medication Change[J].PLoS One,2014,9(3):e92458.
-
7Asaba Kl,Tojo A,Onozato ML,et al.Double-edged action of SOD mimetic in diabetic nephropathy[J].J Cardiovasc Pharmacol,2007,49(1):13-19.
-
8Brott DA,Adler SH,Arani R,et al.Characterization of renal biomarkere for use in clinical trials:biomarker evaluation in healthy volunteers[J].Drug Des Devel Ther,2014,8:227-237.
-
9朱秀敏.超氧化物歧化酶的生理活性[J].当代医学,2011,17(15):26-27. 被引量：64
-
10徐爱蕾,王为,何学贤,于江.血肌酐、糖化血红蛋白、尿微量蛋白联合检测在糖尿病肾病早期诊断中的价值[J].临床军医杂志,2012,40(2):475-476. 被引量：9
-
1王秀清,席文琪,张曼丽.依那普利和缬沙坦及依那普利联合缬沙坦治疗早期糖尿病肾病的疗效观察[J].内蒙古医学杂志,2009,41(S5):201-201.
-
2谷秀兰,李官印,连莲.福辛普利治疗临床糖尿病肾病31例疗效观察[J].临床中老年保健,2003,6(2):118-119.
-
3王肃.黄芪联合胰激肽原酶治疗临床糖尿病肾病疗效观察[J].光明中医,2010,25(12):2290-2290. 被引量：1
-
4张秋生,席绍成.疏血通联合替米沙坦治疗糖尿病肾病的临床观察[J].医学信息（下旬刊）,2010,23(6):106-106.
-
5刘静.前列地尔联合厄贝沙坦对糖尿病肾病的治疗效果及安全性研究[J].糖尿病新世界,2017,20(4):174-175. 被引量：3
-
6乔军,刘俊娜.糖尿病患者肾功能损害过程中血清胱抑素C等肾功能指标的监测应用评价[J].临床医学研究与实践,2017,2(13):25-26. 被引量：4
